Starling Oncology, Inc. (DFPH) Free cash flow 2020–2025
Starling Oncology, Inc. (DFPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.8MFY2025 · since FY2020: -$686,000 → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +8.4% |
| FY2024 | -$30.3M | +25.8% |
| FY2023 | -$40.9M | +39.2% |
| FY2022 | -$67.3M | -89.4% |
| FY2021 | -$35.5M | -5078.9% |
| FY2020 | -$686,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Operating cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total assetsDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →